shutterstock_138095450_13

Prices hiked on 3,400 drugs in first half of 2019

pharmafile | July 4, 2019 | News story | Research and Development, Sales and Marketing abstruse, access, generics, pharma, prescription, pricing 

There have been price hikes on more than 3,400 drugs in the United States in the first six months of 2019, according to analysis by Rx Savings Solutions.

Prices increased by an average of 10.5%, a rate five times higher than the rate of inflation, the analysis says.  

Around 41 drugs saw their prices double, increasing by more than 100%, including one version of the antidepressant Prozac (fluoxetine) the cost of which have increased by 879%  

The number of price hikes has increased by 17% compared to the number of price hikes over the same period of time in 2018, during which period there were 2,900 price increases.

The price hikes have come in spite of pressure from the Trump administration on price hiking firms.

Meanwhile four out of five (79%) of Americans believe the drug prices are unreasonable, while three in ten said they had failed to take prescription medicines because costs were too high.

“In the political climate we live in and the conversations we’re having, that there are more drug price increases this year — you would think that wouldn’t be the case,” said Michael Rea, founder and CEO of Rx Savings Solutions. “It defines the difficulty that consumers have.”

Louis Goss

Related Content

FDA approves IMIDEX’s AI-powered device VisiRad XR

The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …

Artiva Biotherapeutics announces FDA clearance of IND for AlloNK and Rituximab combo

On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeutics’ …

kidney

Novartis acquires Chinook Therapeutics for $3.5bn

Swiss pharmaceutical company Novartis has entered into an agreement and plan of merger with US-based …

Latest content